INmune Bio Inc (INMB)
11.17
-0.19
(-1.67%)
USD |
NASDAQ |
May 16, 16:00
11.12
-0.04
(-0.40%)
After-Hours: 20:00
INmune Bio 1 Year Total Returns (Daily): 49.73% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 16, 2024 | 49.73% |
May 15, 2024 | 45.83% |
May 14, 2024 | 33.29% |
May 13, 2024 | 26.05% |
May 10, 2024 | 14.91% |
May 09, 2024 | 27.46% |
May 08, 2024 | 25.28% |
May 07, 2024 | 38.71% |
May 06, 2024 | 38.96% |
May 03, 2024 | 59.59% |
May 02, 2024 | 44.92% |
May 01, 2024 | 64.07% |
April 30, 2024 | 63.31% |
April 29, 2024 | 62.34% |
April 26, 2024 | 61.75% |
April 25, 2024 | 53.76% |
April 24, 2024 | 39.92% |
April 23, 2024 | 37.96% |
April 22, 2024 | 44.56% |
April 19, 2024 | 0.72% |
April 18, 2024 | 8.64% |
April 17, 2024 | -0.24% |
April 16, 2024 | 5.54% |
April 15, 2024 | 10.50% |
April 12, 2024 | 27.48% |
Date | Value |
---|---|
April 11, 2024 | 36.75% |
April 10, 2024 | 44.53% |
April 09, 2024 | 54.39% |
April 08, 2024 | 51.46% |
April 05, 2024 | 59.08% |
April 04, 2024 | 51.85% |
April 03, 2024 | 46.16% |
April 02, 2024 | 69.50% |
April 01, 2024 | 78.33% |
March 28, 2024 | 74.33% |
March 27, 2024 | 73.32% |
March 26, 2024 | 81.10% |
March 25, 2024 | 78.51% |
March 22, 2024 | 82.63% |
March 21, 2024 | 73.00% |
March 20, 2024 | 86.94% |
March 19, 2024 | 66.26% |
March 18, 2024 | 67.48% |
March 15, 2024 | 62.41% |
March 14, 2024 | 64.60% |
March 13, 2024 | 65.41% |
March 12, 2024 | 70.19% |
March 11, 2024 | 69.61% |
March 08, 2024 | 54.75% |
March 07, 2024 | 50.06% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-71.41%
Minimum
Mar 18 2020
549.8%
Maximum
Mar 18 2021
34.62%
Average
6.07%
Median
Mar 15 2023
1 Year Total Returns (Daily) Benchmarks
Biomarin Pharmaceutical Inc | -16.36% |
Sarepta Therapeutics Inc | -11.00% |
Dare Bioscience Inc | -58.59% |
Zevra Therapeutics Inc | 1.93% |
Kodiak Sciences Inc | -35.74% |